Home / Resource Library / Ibrutinib plus rituximab and mini-CHOP in older patients with newly diagnosed DLBCL: a phase 2 ALLG study

Ibrutinib plus rituximab and mini-CHOP in older patients with newly diagnosed DLBCL: a phase 2 ALLG study

Results of a study investigating ibrutinib combined with chemoimmunotherapy for treatment of DLBCL.